fbpx

How to Address Common Vaccine Safety Concerns for Your Patients

 

With all Americans age 12 and up eligible for the coronavirus (COVID-19) vaccines, now is the perfect time to emphasize vaccine safety in practices across the nation. We need an immunization rate of around 75% to ensure herd immunity against COVID-19. If your patients have vaccine safety concerns, this can greatly affect whether they choose to get themselves and their families vaccinated — not just against COVID-19, but against many other deadly diseases.

Although COVID-19 vaccines were developed quickly, like all vaccines, they have gone through rigorous testing and monitoring to ensure the highest safety and quality standards. What’s more, your practice maintains vaccine safety by carefully storing, monitoring, and administering each vaccine. By educating your patients on all aspects of the vaccine process, you can inform and encourage them to get vaccinated with confidence. 

Read on for all the details you need to explain the safety measures that go into every single vaccine.

Vaccine Safety Testing

No matter what disease they are designed to prevent, vaccines are always developed gradually. This is also true for vaccines containing messenger RNA (mRNA), a genetic material that creates proteins. The Pfizer-BioTech and Moderna COVID-19 vaccines are two examples. These vaccines are synthesized in a laboratory without a large production of the virus, but still undergo the same vaccine safety testing.

After extensive lab testing, vaccines are tested on adult volunteers. Vaccine safety testing takes place in three phases to ensure the safety of volunteers at each clinical trial.

Phase 1

In the first phase of vaccine safety testing, 20 to 100 healthy volunteers receive the vaccine to help determine whether:

  • The vaccine is safe
  • The vaccine seems effective
  • There are any serious side effects
  • There is any link between side effects and dosage size

Phase 2

If the vaccine moves to the second round of vaccine safety testing, several hundred volunteers will receive the vaccine. With more volunteers, scientists can study:

  • The most common side effects
  • How the immune system reacts to the vaccine

Phase 3

During the last phase of vaccine safety testing, thousands of volunteers may be vaccinated. This can demonstrate:

  • Vaccine safety
  • Vaccine efficacy
  • The difference in those who receive the vaccine and those who do not

The Food and Drug Administration (FDA) only approves and licenses vaccines if they are proven to be safe and effective. Some of your patients may have concerns about mRNA vaccine safety, as the first COVID-19 vaccines were developed much more quickly than other vaccines, which often go through years of vaccine safety testing. It’s important to explain that COVID-19 vaccines still went through the same rigorous process.

Scientist carrying out vaccine safety testing

Vaccine Safety Monitoring

Vaccines continue to be monitored after they have been approved by the FDA and recommended for use by the Centers for Disease Control and Prevention (CDC). The US has one of the most advanced tracking systems in the world, ensuring only the safest vaccines are available to your practice.

The FDA regularly inspects facilities to check that vaccines are being made safely and correctly. Manufacturers produce vaccines in lots, which each have to be tested for potency, purity, and sterility. That means every vaccine will be effective and free from additional ingredients or germs.

Federal agencies also track vaccine safety to monitor any side effects and identify any risks. Each agency provides a different aspect of vaccine research to provide a clear picture of overall vaccine safety. Additional efforts have been implemented to provide rapid data collection for increased COVID-19 vaccine safety.

Some of the monitoring agencies include:

Safe Vaccine Administration

Like all medications, vaccines can cause some side effects. These are usually mild and may include a sore arm or drowsiness. While many patients dislike getting vaccines because of these side effects, the benefits of vaccination outweigh some potential short-term discomfort. 

There are some cases, however, where vaccines should not be administered to patients for their safety. Patients with underlying medical conditions or allergies should not receive certain vaccines. In the case of COVID-19 vaccines, patients under the age of 16 should not be vaccinated, nor should anyone who has received any other vaccines within 14 days. You should also monitor patients after vaccination if they are at a higher risk or have additional vaccine safety concerns

All of this information should be clear from patient records and vaccine instructions, but you can also use technology at your practice that only dispenses vaccines for the right patient, at the right time. The AccuVax Vaccine Management System performs safety checks to maximize patient safety and minimize risk by showing whether:

  • The dosage is safe for the patient’s age
  • The patient has already received all the doses in a series
  • The patient received the  previous dose too recently
  • The vaccine is part of the patient’s recommended immunization program

You can help eliminate vaccine safety concerns among your patients by discussing your staff’s thorough training, advanced technology, and experience with their unique medical history.

AccuVax Safety Check Screen

Safe Vaccine Storage

As well as performing safety checks, an advanced vaccine storage system will ensure that vaccines are kept at the correct temperatures and used before their expiration date. This ensures vaccines are safe and effective when your patients are ready to get vaccinated, so they don’t have to feel rushed into making a decision.

The AccuVax Vaccine Management System guarantees correct temperature control for all your vaccines within the same unit. The advanced technology automatically rotates vials by expiration date to prevent any manual efforts, ineffective vaccinations, or waste. To ensure safe vaccine storage with an existing cold storage device, the AccuShelf Inventory Management System provides integration with digital data loggers, so you can monitor temperatures and track vials with ease.

To learn how you can improve the immunization rates at your practice, read our blog post which offers 4 best practices.